Cullen/Frost Bankers’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-500
Closed -$10K – 1077
2022
Q1
$10K Sell
500
-750
-60% -$15.6K ﹤0.01% 941
2021
Q4
$32K Hold
1,250
– – ﹤0.01% 829
2021
Q3
$34K Buy
+1,250
New +$35.8K ﹤0.01% 853

Other funds holding BMEZ

Cullen/Frost Bankers's BMEZ Position: Q2 2022 in Review

Cullen/Frost Bankers sold out of BlackRock Health Sciences Trust II (BMEZ) in Q2 2022, closing a stake of 500 shares — an estimated $10K sold.

Cullen/Frost Bankers first reported a position in BMEZ in Q3 2021 and held it in 3 quarters. The position peaked at $34K in Q3 2021. 78 funds tracked by Wall St. Rank hold BMEZ as of Q2 2022.

  • Cullen/Frost Bankers reported no remaining BlackRock Health Sciences Trust II position as of Q2 2022 after selling out during the quarter.
  • Cullen/Frost Bankers sold 500 BlackRock Health Sciences Trust II shares in Q2 2022, an estimated $10K.
  • Cullen/Frost Bankers first reported a position in BlackRock Health Sciences Trust II in Q3 2021 and held it in 3 quarters.
  • Cullen/Frost Bankers's BlackRock Health Sciences Trust II position peaked at $34K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2022.

Based on Cullen/Frost Bankers's 13F filing for Q2 2022, filed 5 Aug 2022.